Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by James N Ingle

201-250 of 374 results

View this query on the Wikidata Query Service
A comprehensive analysis of breast cancer microbiota and host gene expression.

scientific article published on 30 November 2017
Randomized trial of observation versus adjuvant therapy with cyclophosphamide, fluorouracil, prednisone with or without tamoxifen following mastectomy in postmenopausal women with node-positive breast cancer

scientific article published on 01 September 1988
A phase II study of cis-diamminedichloroplatinum and 5-fluorouracil in advanced upper aerodigestive neoplasms

scientific article published on 01 July 1984
Efficacy of radiotherapy for ovarian ablation: results of a breast intergroup study

scientific article
A promising approach for treatment of tumor-induced bone diseases: utilizing bisphosphonate derivatives of nucleoside antimetabolites

scientific article
p53 gene expression in node-positive breast cancer: relationship to DNA ploidy and prognosis

scientific article published on 01 December 1994
TGFβ Inducible Early Gene-1 Plays an Important Role in Mediating Estrogen Signaling in the Skeleton

scientific article published on January 1, 2014
Inhibition of Cdk2 activity decreases Aurora-A kinase centrosomal localization and prevents centrosome amplification in breast cancer cells.

scientific article published on 27 February 2013
Progress report on two clinical trials in women with advanced breast cancer. Trial I: tamoxifen versus tamoxifen plus aminoglutethimide. Trial II: aminoglutethimide in patients with prior tamoxifen exposure.

scientific article published in August 1982
ERβ inhibits cyclin dependent kinases 1 and 7 in triple negative breast cancer

scientific article published on 11 October 2017
Randomized trial to evaluate the addition of tamoxifen to cyclophosphamide, 5-fluorouracil, prednisone adjuvant therapy in premenopausal women with node-positive breast cancer

scientific article published on 01 April 1989
A design for phase II testing of anticancer agents within a phase III clinical trial

scientific article published on June 1, 1988
ERβ-mediated induction of cystatins results in suppression of TGFβ signaling and inhibition of triple-negative breast cancer metastasis

article published in the Proceedings of the National Academy of Sciences of the United States of America
Complications of therapy and a diagnostic dilemma case. Case 3. Diagnostic dilemma: sarcoidosis simulating metastatic malignancy

scientific article published in December 2003
Results of salvage hormonal therapy and salvage chemotherapy in women failing adjuvant chemotherapy after mastectomy for breast cancer

scientific article published on 01 March 1989
Two‐Phase Designs to Follow‐Up Genome‐Wide Association Signals With DNA Resequencing Studies

scientific article published on January 24, 2013
Phase II study of high-dose tamoxifen (NSC-180973) in patients with disseminated malignant melanoma

scientific article published on 01 April 1982
Identification of a broad coverage HLA-DR degenerate epitope pool derived from carcinoembryonic antigen.

scientific article published on 21 July 2009
A degenerate HLA-DR epitope pool of HER-2/neu reveals a novel in vivo immunodominant epitope, HER-2/neu88-102.

scientific article
Randomized trial of doxorubicin alone or combined with vincristine and mitomycin C in women with metastatic breast cancer

scientific article
Evaluation of tamoxifen plus letrozole with assessment of pharmacokinetic interaction in postmenopausal women with metastatic breast cancer

scientific article published on 01 July 1999
Phase I evaluation of preirradiation chemotherapy with carmustine and cisplatin and accelerated radiation therapy in patients with high-grade gliomas.

scientific article published on 01 January 1999
Lipid concentrations in postmenopausal women on letrozole after 5 years of tamoxifen: an NCIC CTG MA.17 sub-study

scientific article published on October 23, 2012
Calmodulin-like protein 3 is an estrogen receptor alpha coregulator for gene expression and drug response in a SNP, estrogen, and SERM-dependent fashion

scientific article published on 18 August 2017
Randomized trial of thoracic irradiation plus combination chemotherapy for unresectable adenocarcinoma and large cell carcinoma of the lung

scientific article published on August 1, 1979
TCL1A Single-Nucleotide Polymorphisms and Estrogen-Mediated Toll-Like Receptor-MYD88-Dependent Nuclear Factor-κB Activation: Single-Nucleotide Polymorphism- and Selective Estrogen Receptor Modulator-Dependent Modification of Inflammation and Immune

scientific article published on 14 June 2017
Ketamine and ketamine metabolites as novel estrogen receptor ligands: Induction of cytochrome P450 and AMPA glutamate receptor gene expression

scientific article published on 2 April 2018
The lncRNA MIR2052HG regulates ERα levels and aromatase inhibitor resistance through LMTK3 by recruiting EGR1

Osteoporosis therapy and outcomes for postmenopausal patients with hormone receptor-positive breast cancer: NCIC CTG MA.27.

scientific article published on 2 May 2017
Early Clinical Study of an Intermittent Schedule for Maytansine (NSC-153858): Brief Communication 2

scientific article published on January 1, 1978
Inhibition of the Aurora A kinase augments the anti-tumor efficacy of oncolytic measles virotherapy

scientific article published on August 14, 2015
An evaluation of two schedules of VP-16 and adriamycin in patients with advanced breast cancer

scientific article published on 01 January 1980
Evaluation of piroxantrone in women with metastatic breast cancer and failure on nonanthracycline chemotherapy

scientific article published on 01 September 1994
A phase II trial of docetaxel and carboplatin as first-line chemotherapy for metastatic breast cancer: NCCTG study N9932.

scientific article published on 23 August 2005
Phase II study of cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum (II) by infusion in patients with adenocarcinoma and large cell carcinoma of the lung

scientific article published on September 1, 1979
5-Fluorouracil plus leucovorin in women with metastatic breast cancer. A phase II study

scientific article published on February 1991
A case for preplanned thoracic and prophylactic whole brain radiation therapy in limited small-cell lung cancer

scientific article published on 01 January 1981
A phase II trial of a combination of pemetrexed and gemcitabine in patients with metastatic breast cancer: an NCCTG study

scientific article
Quality of Life From Canadian Cancer Trials Group MA.17R: A Randomized Trial of Extending Adjuvant Letrozole to 10 Years

scientific article published on 12 January 2018
National Cancer Institute of Canada Clinical Trials Group MAP.3 Trial: evaluation of exemestane to prevent breast cancer in postmenopausal women

scientific article published in December 2007
Chemotherapy for advanced head and neck cancer with the combination adriamycin, cyclophosphamide, and cis-diamminedichloroplatinum (II): preliminary assessment of a one-day vs. three-day drug regimen

scientific article published on 01 June 1981
CYP2D6 Genotype and Tamoxifen: Considerations for Proper Nonprospective Studies

scientific article published on August 1, 2014
CYP2D6 genotype and tamoxifen response

scientific article
Prognostic factors for patients with carcinoma of the breast

scientific article published on July 1995
Octreotide as first-line treatment for women with metastatic breast cancer

scientific article published on 01 January 1996
Phase III double-blind, placebo-controlled, prospective randomized trial of adjuvant tamoxifen vs. tamoxifen and fenretinide in postmenopausal women with positive receptors (EB193): an intergroup trial coordinated by the Eastern Cooperative Oncology

scientific article published on 28 September 2010
Breast cancer chemoprevention pharmacogenomics: Deep sequencing and functional genomics of the ZNF423 and CTSO genes

scientific article published on 21 August 2017
SNPs near the cysteine proteinase cathepsin O gene (CTSO) determine tamoxifen sensitivity in ERα-positive breast cancer through regulation of BRCA1

scientific article published on 2 October 2017
Comparison of estrogen receptor determinations by a biochemical ligand-binding assay and immunohistochemical staining with monoclonal antibody ER1D5 in females with lymph node positive breast carcinoma entered on two prospective clinical trials

scientific article published on 01 August 1996
Phase II study of tamoxifen in patients with disseminated malignant melanoma

scientific article published on 01 February 1980

Paulina is supported by:

About Paulina

Help